ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM
SINGAPORE, June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCPK: ALRTF), the diabetes management company,...
Australian Cyclist Jerry Rides 2,800km Across China from Zhongshan to Hohhot
ZHONGSHAN, China, June 25, 2025 /PRNewswire/ -- A report from Zhongshan Daily & Zhongshan International Communications Center: jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" Australian...
ARTERY Drives Exoskeleton Innovation with AT32 MCU for Smart Medical Applications
TAIPEI, June 25, 2025 /PRNewswire/ -- In recent years, exoskeleton robots have gained traction in various countries, including Japan, Germany,...
Seerslab Launches ‘AInoon’ : Affordable AI Glasses Now on Kickstarter
Y Combinator Alum Seerslab Launches AInoon: Affordable AI Glasses Now on Kickstarter The $174 wearable provides seamless, intuitive access to...
Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders’ Meeting Today
TAIPEI and SAN DIEGO, June 25, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, held its...
2025 China Energy Internet Conference Wraps Up in Hangzhou
HANGZHOU, China, June 25, 2025 /PRNewswire/ -- 2025 China Energy Internet Conference wrapped up in Hangzhou, China, on June 21....
From Vision to Action: CIIE Empowers Global Development Through Inclusive Cooperation
SHANGHAI, June 25, 2025 /PRNewswire/ -- Amid growing global uncertainty and anti-globalization sentiment, the China International Import Expo (CIIE) remains...
FPT AI Factory Listed TOP 500 World’s Fastest Supercomputers, #1 Commercial Cloud Provider in Japan
HANOI, Vietnam, June 25, 2025 /PRNewswire/ -- Two AI Factories developed by FPT Corporation have been listed in the latest global...
EDAN Establishes Mexico Subsidiary to Strengthen Presence in the Americas
MEXICO CITY, June 25, 2025 /PRNewswire/ -- EDAN Instruments, Inc. (300206.SZ), a healthcare company and medical device manufacturer, officially celebrated...
QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
BRISBANE, Australia, June 25, 2025 /PRNewswire/ -- jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" QBiotics CEO, Stephen Doyle, reflecting on Soft Tissue Sarcoma data jwplayer('myplayer1').setup({file:...
Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.
📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com